Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about our Research & Development Process

Utilizing our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

Pipeline Graphic
New Releases

Thursday, July 23, 2015 | Anacor Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 6, 2015
Monday, July 13, 2015 | Anacor Pharmaceuticals Announces Positive Top-Line Results From Two Phase 3 Pivotal Studies of Crisaborole Topical Ointment, 2% in Patients With Mild-to-Moderate Atopic Dermatitis
Sunday, July 12, 2015 | Anacor Pharmaceuticals to Host Conference Call Tomorrow, July 13, 2015 at 7:30 A.M. ET to Discuss Top-Line Results From Crisaborole Phase 3 Pivotal Studies in Patients With Mild-to-Moderate Atopic Dermatitis
New Releases Graphic